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ABSTRACT
Background The review of clinical data extraction
from electronic records is increasingly being used as
a tool to assist general practitioners (GPs) manage
their patients in Australia. Type 2 diabetes (T2DM)
is a chronic condition cared for primarily in the
general practice setting that lends itself to the
application of tools in this area.
Objective To assess the feasibility of extracting
data from a general practice medical record soft-
ware package to predict clinically signiﬁcant out-
comes for patients with T2DM.
Methods A pilot study was conducted involving
two large practices where routinely collected clini-
cal datawere extracted and inputted into theUnited
Kingdom Prospective Diabetes Study Outcomes
Model to predict life expectancy. An initial assess-
ment of the completeness of data available was
performed and then for those patients aged between
45 and 64 years with adequate data life expectancies
estimated.
Results A total of 1019 patients were identiﬁed as
current patients with T2DM. There were suﬃcient
data available on 40% of patients from one practice
and 49% from the other to provide inputs into the
UKPDS Outcomes Model. Predicted life expect-
ancy was similar across the practices with women
having longer life expectancies thanmen. Improved
compliance with current management guidelines
for glycaemic, lipid and blood pressure control was
demonstrated to increase life expectancy between
1.0 and 2.4 years dependent on gender and age
group.
Conclusion This pilot demonstrated that clinical
data extraction from electronic records is feasible
although there are several limitations chieﬂy caused
by the incompleteness of data for patients with
T2DM.
Keywords: clinical informatics, diabetes, life ex-
pectancy, primary care
What this paper adds
. Conﬁrms the feasibility of accessing routinely collected electronic data on diabetes mellitus management
in an Australian general practice setting.
. Demonstrates that estimates of health outcomes for people with type 2 diabetes mellitus can be generated
using these data.
. Highlights the need for further research to fully realise the potential of applying computer models in a
general practice setting to evaluate chronic disease management strategies.
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Introduction
Type 2 diabetes (T2DM) has reached epidemic pro-
portions in developed countries such as Australia, has
become one of themost common non-communicable
diseases in the world and results in substantial mor-
bidity and mortality.1 The disease is primarily man-
aged in general practice and is often the focus of
initiatives aimed at improving the care of patients
with chronic medical conditions.2,3
With the increasing computerisation of general
practice in Australia the use of clinical data extraction
as a tool to assist practitioners manage their patients
and participate in quality improvement activities has
increased.4 The Australian experience has largely fo-
cused on practice level compliance with clinical care
parameters such as the proportion of patients with
diabetes having a recent glycosylated haemoglobin
(HbA1c) level below the target level.
General practice records can provide a very rich
source of data that can be used to research chronic
conditions such as T2DM provided ethical and priv-
acy issues are adequately addressed.5 With the advent
and reﬁnement of diabetes modelling software6 this
data potentially could be used to predict clinical
outcomes for patients and be employed as a measure
of the eﬀectiveness of various chronic care inter-
ventions.
The aims of this pilot study are to assess the
feasibility of extracting data suitable for use in mod-
elling clinical outcomes from one of the more popular
medical record software packages being used in
Australian general practice, and to test whether these
data can be successfully inputted into the United
Kingdom Prospective Diabetes Study (UKPDS) Out-
comesModel7 to predict clinically signiﬁcant outcomes.
Methodology
Recruitment of general practitioners
Two general practices were identiﬁed among those
who participated in a recently established general
practitioner inﬂuenza surveillance programme that
utilises electronic medical record data extractions.8
Practices had to be fully computerised for clinical
notes, use the Best Practice9 medical record software
(a common platform used in Australian general prac-
tice) and routinely receive patient laboratory results
via Health Level seven (HL7) messaging to be eligible
for inclusion in the pilot. Information technology
terms are given in Box 1.
Best Practice software
This software provides a comprehensive electronic
medical record capacity, uses a Microsoft SQL server
database and is typically installed on a local network in
the Australian general practice setting. Data on pre-
senting complaints, clinical measurements, past his-
tory, social history and medication history are readily
recorded both through the use of drop-down menus
with automated coding and by free text recording. The
software has a capacity to receive Health Language
Box 1 Information Technology Terms
SQL (Structured Query Language)
A standardised query language for requesting information from a database. It is an American National
Standards Institute (ANSI) standard.
ODBC (Open Database Connectivity)
A standard database access method that allows access to data regardless of the database management system
(DBMS) handling the data.
Microsoft SQL Server
A relational database server that was developed by Microsoft. It stores and retrieves data for other software
applications to use.
HL7 (Health Level seven)
A standard for exchanging electronic information between medical applications. It deﬁnes a format for the
transmission of electronic health-related information such as patient records, laboratory records and billing
information.
CSV (Comma Separated Value)
A ﬁle format that stores numbers and text in a plain text form delineated by commas.
Data extraction from GPs’ electronic records to predict clinical outcomes in type 2 diabetes 97
seven (HL7) messages from laboratories for automated
inclusion of results into individual patient records.
Data extraction and manipulation
Data were extracted from participating general prac-
tices onsite using ODBCView, a free SQL query tool
used to view and export data from any OBDC data-
base.10 This process generated CSV ﬁles that were
manipulated by the statistical software program
STATA11 to produce the required input text ﬁle for
the standalone version of theUKPDSOutcomeModel
software.12
Diabetes prediction modelling
The UKPDS Outcomes Model was used to predict
major diabetes-related complications for type 2 dia-
betics (T2Ds) who attend the pilot practices.7,12 T2Ds
were identiﬁed through interrogation of both Best
Practice internal codes and free text past history ﬁelds.
There are multiple diagnosis ﬁeld ‘drop-down’ op-
tions within Best Practice that are consistent with a
diagnosis of T2D and these are internally assigned to
either the internal code 374 or 378. Free text searching
looked for the following terms; NIDDM, non-insulin
diabetes mellitus, diabetes, type 2 and type II and
excluded IDDM, insulin-dependent diabetes mellitus
and type I. Patients who were recorded as having
diabetes, but not categorised as insulin dependent or
not, were excluded if they had a record of having been
prescribed an exogenous insulin preparation. Pre-
dicted life expectancy is presented as the major out-
come of interest. The minimum input dataset required
to run the model and how these parameters were
represented are described in Table 1.
Table 1 Input parameters for UKPDS Outcomes Model
Parameter How calculated Comment
Gender From patient details
Age at diagnosis Calculated from date of birth
Ethnicity Defaulted to ‘white’ Very poorly coded, default used
Duration of diabetes (years) From ‘past history’ record
Current clinical
Glycosylated haemoglobin (%) Average of calendar year
measurements
‘Current date’ – ‘09 or ‘10
Smoking status (never, past,
current)
From social history
Cholesterol Average of calendar year
measurements
 1 year from ‘current date’
HDL Average of calendar year
measurements
 1 year from ‘current date’
Systolic blood pressure (mmHg) Average of calendar year readings  1 year from ‘current date’
Height (m) From observation records Any recording within 5 years of
‘current date’
Weight (kg) Average of calendar year
measurements
 1 year from ‘current date’
Clinical at diagnosis
Atrial ﬁbrillation present From ‘past history’ record
Peripheral vascular disease
present
From ‘past history’ record
Cholesterol Current reading if missing
HDL Current reading if missing
Systolic blood pressure Current reading if missing
Glycosylated haemoglobin 7, 9 or 11% if missing Sensitivity analysis
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The study considered data recorded between 2001
and 2010 for patients aged 45–64 years and considered
as ‘current patients’ as at 2011. For a patient to be
included in the model there needed to be a record of
the minimum dataset variables collected at least once
in the calendar years 2009 or 2010.
Life expectancy was calculated in two ways; ﬁrst,
including the parameters listed in Table 1 only and
second, including parameters inTable 1 plus projected
yearly data from 2011 onwards. The projected data
were set as either the upper level of target parameters
or the current level (if that was lower) and smoking
status was either maintained as non or past smoking
or, for current smokers, set to past smoking. This was
done in order to demonstrate the potential beneﬁts
that could be achieved by meeting recommended
management guidelines. The target parameters used
were; HbA1c 48 mmol/mol (6.5%), cholesterol 4.0
mmol/L, high-density lipoprotein (HDL) 1.0 and
systolic blood pressure 140 mmHg.
UKPDS Outcome Modelling
parameters
The model needs to deal with ﬁrst-degree (Monte-
Carlo variability) and second-degree (statistical varia-
bility) uncertainty.13 First-degree uncertainty arises in
the model because an individual’s chances of devel-
oping one diabetes-related event may inﬂuence the
risk of experiencing another in the future. The model
allows for this by running multiple simulations that
vary the order in which event equations are calcu-
lated.7 Statistical variability is dealt with by applying a
bootstrap procedure.14 The UKPDSOutcomesModel
user needs to specify both the number ofMonte-Carlo
trials and bootstraps used; in this study, 1000 trials and
1000 bootstraps were employed.15
Sensitivity analysis
The diﬃculty in obtaining clinical parameters at the
time of the diagnosis of T2DMrequired the estimation
of these parameters formany individuals.Where levels
for cholesterol, HDL and systolic blood pressure at
diagnosis were not recorded, they were estimated as
the level recorded in 2009/10. A life expectancy sensi-
tivity analysis was done to explore the impact of
unknown HbA1c levels at diagnosis by substituting
7, 9 and 11% (53, 75 and 97mmol/mol) as this level for
patients without recorded levels. Where the HbA1c
level at diagnosis was recorded this was used and no
substitution performed.
Ethics
The study was approved by the Northern Sydney
Health Service Ethics Committee and appropriate
data custodian protocols implemented. Only non-
identiﬁable data were extracted frommedical records.
The UKPDS Outcomes Model was used under aca-
demic licence from the University of Oxford, UK.
Results
Practice details
There were two practices included in this pilot study.
Practice 1 had 17 full- or part-time general prac-
titioners (GPs) and performed approximately 1500
consultations per week. Practice 2 had 5 full- or part-
time GPs and performed 400 consultations per week.
A total of 1019 current T2Ds were identiﬁed from the
two practices. The median duration of diabetes dif-
fered between the practices with medians of 3 and 7
years for practice 1 and practice 2, respectively.
Completeness of input parameters
Table 2 describes the proportion of T2D recordswhere
suﬃcient data on clinical input parameters for the
UKPDS Outcomes Model were able to be extracted.
Forty percent of current T2Ds had the required inputs
formodelling frompractice 1with a higher percentage
of 49% available from practice 2 records.
Predicted life expectancy by UKPDS
Outcomes Model
Table 3 presents the modelled life expectancies of
T2Ds considered as a group for each general practice
by 10-year age groups. Predicted life expectancy was
similar between practices with females having longer
life expectancies than males in general. Table 3 also
demonstrates that the sensitivity analysis looking at
the eﬀect of varying the HbA1c at diagnosis had little
eﬀect on life expectancies. Forty-nine of the 176 (28%)
modelled individuals had HbA1c levels at diagnosis
recorded.
The eﬀect of incorporating future annual clinical
parameters equal to guideline levels is displayed in
Table 4. It can be seen that between 1.0 and 2.4 years of
additional years of life can be expected when com-
paring these levels with those estimated using default
predicted clinical parameter levels included in the
model.
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Discussion
This pilot study found that it was feasible to identify
the electronic medical records of patients with T2D
produced by a software package commonly used
within Australia general practice and extract data to
predict life expectancy and complications for this
group of patients. Although somewhat disappointing,
40–50% of current T2D patients’ records provided
suﬃcient model inputs to allow meaningful predic-
tions to be made. The estimates of life expectancies
Table 2 Type 2 diabetic patients with UKPDS Outcomes Model input parameters available
from electronic their electronic medical record
Parameter Practice 1 (N = 881) Practice 2 (N = 138)
no. % no. %
Glycosylated haemoglobin (%) 585 66.4 81 58.7
Cholesterol (mmol/L) 580 65.8 80 58.0
HDL cholesterol (mmol/L) 563 63.9 80 58.0
Systolic blood pressure (mmHg) 535 60.7 80 58.0
Smoking status (never, past,
current)
715 81.2 131 94.9
Height (m) 574 65.2 126 91.3
Weight (kg) 472 53.6 71 51.4
All required parameters 349 39.6 67 48.6
Table 3 Modelled life expectancy, sensitivity analysis for glycosylated haemoglobin levels
(HbA1c) at diagnosis of type 2 diabetes
Practice 1 Practice 2
Age group
(years)*
No. Diagnosis
HbA1c (%)
Life
expectancy
(years)
95% CI No. Diagnosis
HbA1c (%)
Life
expectancy
(years)
95% CI
Males
45–54 29 7 22.5 (19.9, 25.0) 4 7 20.9 (18.4,23.5)
9 22.2 (19.7, 24.7) 9 20.6 (18.1, 23.1)
11 22.0 (19.6, 24.4) 11 20.8 (18.4, 23.2)
55–64 62 7 16.4 (14.9, 18.0) 12 7 15.8 (14.0, 17.5)
9 16.3 (14.7, 17.8) 9 15.7 (14.0, 17.4)
11 16.2 (14.7, 17.7) 11 15.5 (13.8, 17.1)
Females
45–54 19 7 23.4 (20.5, 26.3) 5 7 23.6 (20.5, 26.7)
9 23.3 (20.4, 26.1) 9 23.4 (20.3, 26.5)
11 23.1 (20.3, 25.9) 11 23.2 (20.1, 26.2)
55–64 35 7 17.9 (16.0, 19.8) 10 7 19.1 (17.1, 21.1)
9 17.8 (15.9, 19.6) 9 18.8 (16.9, 20.8)
11 17.6 (15.8, 19.4) 11 18.7 (16.8, 20.6)
* Based on age of patient in 2009 or 2010.
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made are similar to those reported by UKPDS Group
when they applied the model to the UKPDS popu-
lation.7
The ﬁndings of this pilot study are important
because they demonstrate that routinely collected
clinical data can be used to directly estimate the eﬀect-
iveness of diabetes management strategies in terms of
clinical outcomes. Doing so removes the need to rely
on the assumption that meeting prescribed guidelines
and targets will result in signiﬁcant clinical beneﬁt.
A recent literature review identiﬁed that informa-
tion technology has been successfully used to provide
clinicians with data on both process and clinical
measures of diabetes care in the primary care setting.
These data have, in turn, been used to enhance health-
care delivery.16 A variety of strategies have been used
including the use of diabetic patient registers, tracking
HbA1c tests, point of care decision support tools and
clinician reminders.17–19 These strategies have mainly
been evaluated in a quality improvement framework
and in some cases required the augmentation of
existing electronic medical record systems.17
While it is acknowledged that data extraction tools
can be very useful for identifying, quantifying and
monitoring clinical practice issues, considerable tech-
nical barriers have been identiﬁed that potentially
limit their usefulness.2,20 These include some short-
comings of data extraction tools,20 variation in record-
ing of data,21 comprehensive data entry20 and accept-
ance of practice staﬀ.22 However, even given these
limitations others have still reported that roughly half
of patients with T2DM have recent data available for
HbA1c, cholesterol and systolic blood pressure in their
electronic record.20
Despite there being a variety of software and ven-
dors across the healthcare industry in Australia the
widespread use of the HL7 standard has enabled near
real-time electronicdeliveryofpathology results.23 It is
likely that this has already resulted in a larger amount
of clinical data relevant to diabetesmanagement being
available toGPs.Developments such as this alongwith
continued interest and support in quality improve-
ment initiatives based upon the use of electronic data
recording2,4 should help overcome the barriers ident-
iﬁed above.
The UKPDS Outcomes Model requires consider-
able individual-level clinical data to be inputted in
order to make predictions. A major issue highlighted
by the current study is that data on clinical parameters
such as HbA1c at the time of diabetes diagnosis are
unlikely to be routinely available. The developers of
the software have anticipated this and suggested two
options to overcome this problem.24 First, to conduct
a sensitivity analysis (as done in this study) for some
variables or, second, to predict risk factors directly and
input these as a series of future annual data. The
sensitivity analysis done in this study demonstrated
that the paucity of data on HbA1c at diagnosis had
little impact on estimated life expectancies.
The inclusion of projected risk factor data based
upon management guideline targets demonstrated
that improved management of patients could achieve
up to an additional 2.4 years of life expectancy. This
beneﬁt, important in itself, may be even more so if the
patients included in the modelling were those with
better disease management and control.
There are several limitations to the current study.
First, it is a pilot and as such requires the participation
Table 4 Modelled life expectancy using predicted annual clinical parameters based on
current management guidelines for type 2 diabetes
Practice 1 Practice 2
Age group
(years)*
No. Life
expectancy
(years)
95% CI Diﬀerence
(years){
No. Life
expectancy
(years)
95% CI Diﬀerence
(years){
Male
45–54 29 24.4 (21.4, 27.5) 2.4 4 22.8 (19.7, 15.9) 2.2
55–64 62 18.0 (16.1, 20.0) 1.8 12 17.4 (15.2, 19.6) 1.9
Female
45–54 19 24.2 (21.0, 27.4) 1.1 5 24.2 (20.8, 27.6) 1.0
55–64 35 18.9 (16.7, 21.1) 1.7 10 19.9 (17.6, 22.2) 1.2
* Based on age of patient in 2009 or 2010. # Life expectancy in Table 4 – life expectancy in Table 3.
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of a greater number of practices to conﬁrm its
ﬁndings. Second, outcomes were predicted for only
those individuals with a complete baseline dataset and
it is reasonable to suspect that these individuals were
more likely to present for routine care on a regular
basis. Consequently, theymay well have better control
of their disease than the other diabetic patients from
the practice and the outcomes reported at a practice
level such as life expectancy may well be an overesti-
mate due to selection bias.
The UKPDSOutcomesModel was developed using
the data from theUnited KingdomProspectiveDiabetes
Study25 and has yet to be validated in an Australian
setting. There have been attempts to test cardio-
vascular risk equations derived from this study in
Australian patients with type 2 diabetes using data
collected as part of the Fremantle Diabetes Study.26
The authors attempted to validate the UKPDS risk
engine among 791 T2Ds recruited from a single urban
centre and concluded that its underlying equations are
not suitable for predicting risk in Australians. It
should, however, be emphasised that the UKPDS
Outcomes Model diﬀers from the UKPDS risk engine
in that it has considerably more input data, includes
information on previous events and can take account
of updated risk factor data over time.
Another limitation of the study is related to the
ability of the UKPDS Outcomes Model to predict life
expectancy at an individual level. Although the model
reports predictions at an individual level it should be
emphasised that the uncertainty of an estimated life
expectancy for any individual patient is likely to be
substantial.7 As such more reliance should be placed
on practice-level predictions which are much more
robust.
This pilot study raises the need for further research.
It is important that its ﬁndings are replicated on a
larger scale and when using other medical software
packages. Further research into the barriers faced by
GPs when challenged to improve the quality of elec-
tronic medical and how these could be overcome
should be encouraged.
Data extraction from electronic medical records
routinely used in the Australian general practice
setting can be used to predict clinical outcomes among
T2D patients at a practice level. The outcomes pre-
sented in this pilotmay be limited by selection bias and
the validity of the underlying model upon which they
are based is yet to be established in an Australian
setting. Nevertheless, this pilot study highlights how
routinely collected data could be used to estimate the
clinical impact of diabetes management strategies in
the general practice setting.
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